As additional evidence, immunoblotting performed on 2-week-old iMNs confirmed elevated BiP and GRP75 expression in C9ORF72-ALS/FTD patient-derived iMNs (Fig. 1e). This evidence concerns the gene HSPA9 and frontotemporal dementia.